MedPath

湖北同济奔达鄂北制药有限公司

Ownership
-
Established
2004-06-16
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

60

NMPA:60

Drug Approvals

Carbazochrome Injection

Product Name
肾上腺色腙注射液
Approval Number
国药准字H42021057
Approval Date
Oct 24, 2012
NMPA

Gentamycin Sulfate Injection

Product Name
硫酸庆大霉素注射液
Approval Number
国药准字H42021051
Approval Date
Oct 24, 2012
NMPA

Vitamin B12 Injection

Product Name
维生素B12注射液
Approval Number
国药准字H42021058
Approval Date
Oct 24, 2012
NMPA

Lidocaine Hydrochloride Injection

Product Name
盐酸利多卡因注射液
Approval Number
国药准字H42021038
Approval Date
Oct 24, 2012
NMPA

Vitamin B1 Injection

Product Name
维生素B1注射液
Approval Number
国药准字H42021062
Approval Date
Oct 24, 2012
NMPA

Lidocaine Hydrochloride Injection

Product Name
盐酸利多卡因注射液
Approval Number
国药准字H42021039
Approval Date
Oct 24, 2012
NMPA

Metamizole Sodium Injection

Product Name
安乃近注射液
Approval Number
国药准字H42021044
Approval Date
Oct 24, 2012
NMPA

Procaine Hydrochloride Injection

Product Name
盐酸普鲁卡因注射液
Approval Number
国药准字H42021254
Approval Date
Oct 24, 2012
NMPA

Vitamin B12 Injection

Product Name
维生素B12注射液
Approval Number
国药准字H42021060
Approval Date
Oct 24, 2012
NMPA

Riboflavin Sodium Phosphate Injection

Product Name
核黄素磷酸钠注射液
Approval Number
国药准字H20123227
Approval Date
Aug 2, 2012
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.